Today: 29 April 2026
Intuitive Machines stock jumped 11% Friday — here’s what matters before the next trade
18 January 2026
1 min read

Intuitive Machines stock jumped 11% Friday — here’s what matters before the next trade

New York, Jan 18, 2026, 07:39 EST — Market closed

  • Intuitive Machines shares jumped 10.7% on Friday, adding to the stock’s recent rollercoaster ride.
  • Traders are scrutinizing the deal and financing specifics linked to its Lanteris acquisition
  • U.S. markets will be closed Monday; trading resumes Tuesday

Intuitive Machines’ stock ended Friday up 10.7%, closing at $21.58 after moving between $19.37 and $22.40 during the session. That push boosted the Nasdaq-listed company’s market cap to roughly $3.9 billion.

U.S. stock markets are closed Monday in observance of Martin Luther King Jr. Day. The real test for investors will come when trading resumes Tuesday morning.

Why it matters now: Intuitive Machines remains a high-beta play, where positioning can quickly become skewed. Finviz data puts short interest at about 25% of the free float, setting the stage for sharp moves in either direction.

Shares surged Friday, following the company’s announcement that it wrapped up its $800 million purchase of Lanteris Space Systems, previously known as Maxar Space Systems. The deal broke down into $450 million in cash and $350 million in stock. CEO Steve Altemus described it as “a defining moment,” noting, “With Lanteris, we add flight-proven manufacturing at scale.” Securities and Exchange Commission

A securities filing detailed the mechanics behind the deal—and highlighted some key restrictions. The company noted the seller secured registration rights tied to the stock consideration. Lender consents included a Stifel Bank waiver that paused borrowing and suspended certain covenants. It also revealed an orbital receivables purchase facility with ING Belgium, capped at $250 million and effective through Dec. 1, 2026. The filing added that financial statements and pro forma details for the acquisition would follow in an amended Form 8-K, due within 71 calendar days.

Registration rights might seem like a technical detail, but traders keep an eye on them since they allow big shareholders to sell stock faster once shares are registered. Simply put, they can cast a shadow over the stock, even if the company’s fundamentals are getting stronger.

Investors are also digging into the receivables facility. This financing setup leans on customer payments for backing. But it can come with make-whole fees and stricter terms if customers pay early or schedules shift.

The risk is clear: integration may falter, and the lender’s “line freeze” clause underscores how capital could suddenly become scarce when flexibility is crucial. For a firm deeply reliant on government space budgets and complex hardware projects, delays and cost overruns can quickly pile up.

Traders will be keen to see if the post-holiday session maintains Friday’s gains and if follow-on filings shed light on leverage, cash flow, and Lanteris’ financial standing. The next quarterly results are slated for around March 24, per Zacks’ earnings calendar.

Stock Market Today

  • Zacks Ranks Air China, Amplify Energy, Amerant Bancorp as Strong Sell on April 29
    April 29, 2026, 6:06 AM EDT. Zacks Investment Research added Air China (AIRYY), Amplify Energy (AMPY), and Amerant Bancorp (AMTB) to its Rank #5 (Strong Sell) list for April 29. Air China's earnings estimate dropped 78.3% over 60 days amid persistent challenges in the airline sector. Amplify Energy saw a 48.5% downward revision reflecting pressures in oil and gas exploration. Amerant Bancorp's estimate fell 7.6%, indicating caution in the banking services space. Conversely, Zacks highlighted a new top semiconductor stock positioned to benefit from the booming demand in Artificial Intelligence and IoT, with the industry expected to grow from $452 billion in 2021 to $803 billion by 2028.

Latest article

These 5 Penny Tech Stocks Are Back in Focus as AI Jitters Hit Nasdaq

These 5 Penny Tech Stocks Are Back in Focus as AI Jitters Hit Nasdaq

29 April 2026
Shares of five U.S.-listed AI penny stocks, including Fabric.AI, Kopin, Blaize, RedCloud, and U-BX Technology, traded below $5 as tech stocks wobbled ahead of major earnings. Fabric.AI announced a $21.5 million private placement and a shift to AI data center infrastructure. Kopin reported a $15 million development order from Fabric.AI. Blaize unveiled a partnership with Nokia and PT Datacomm for AI deployment in Southeast Asia.
Quantum Stocks With Growth Potential in April-May 2026: 4 Names Facing a May Reality Check

Quantum Stocks With Growth Potential in April-May 2026: 4 Names Facing a May Reality Check

29 April 2026
IonQ, Rigetti, and D-Wave will report earnings between May 6 and May 12, with investors watching revenue, bookings, and cash burn. IonQ shares last traded at $43.08, Rigetti at $16.39, D-Wave at $18.11, and Quantum Computing Inc. at $8.57, all with negative price-to-earnings ratios. IonQ announced a quantum-safe network project in Florida. The sector faces pressure from new IPOs and SPACs.
Best Stocks to Buy Today: 5 Earnings Stocks Wall Street Is Watching Before the Fed Decision

Best Stocks to Buy Today: 5 Earnings Stocks Wall Street Is Watching Before the Fed Decision

29 April 2026
Seagate shares jumped 16% in extended trading after forecasting fourth-quarter revenue above estimates and reporting strong third-quarter results. HSBC upgraded U.S. equities to “overweight” following robust earnings, with 84% of reporting companies beating Wall Street forecasts. Bloom Energy raised its 2026 outlook after posting a 130% revenue jump. Coca-Cola lifted its annual profit forecast after beating expectations.
Micron stock jumps into a holiday-shortened week after $1.8 billion Taiwan fab move
Previous Story

Micron stock jumps into a holiday-shortened week after $1.8 billion Taiwan fab move

Eli Lilly stock price: What to watch after Friday’s close as FDA review scrutiny and Novo’s pill data hit
Next Story

Eli Lilly stock price: What to watch after Friday’s close as FDA review scrutiny and Novo’s pill data hit

Go toTop